Skip to main content
Clinical Trials/ACTRN12612000546853
ACTRN12612000546853
Completed
Phase 4

Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: randomised control trial

Farrukh Aslam Khalid0 sites120 target enrollmentMay 23, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Farrukh Aslam Khalid
Enrollment
120
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 23, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Farrukh Aslam Khalid

Eligibility Criteria

Inclusion Criteria

  • Age above 12 years/either sex
  • Keloid or hypertrophic scar more than 10mm in size measured clinically

Exclusion Criteria

  • History of treatment for scar taken in last 6 months
  • History of chronic renal failure or serum creatinine \> 1\.2mg/dl.
  • Abnormalities in liver function tests (ALT \> 35 IU) and blood counts (WBC \< 4 or \> 11 thousand cells) on laboratory investigations.
  • Pregnant/lactating women or planning pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials